Delisting of Securities from The Nasdaq Stock Market
Nasdaq (NASDAQ:NDAQ) has announced the delisting of securities from multiple companies from The Nasdaq Stock Market. The affected companies include Digital Brands Group, Lipella Pharmaceuticals, ZyVersa Therapeutics, Crown LNG Holdings, Brainstorm Cell Therapeutics, Wag! Group, Ontrak, TPI Composites, Embrace Change Acquisition Corp, and ModivCare.
All these securities were previously suspended from trading between December 2024 and August 2025 and haven't traded on Nasdaq since their respective suspension dates. The delistings affect various types of securities including common stocks, warrants, ordinary shares, units, and rights.
La Nasdaq (NASDAQ:NDAQ) ha annunciato il delisting di titoli di diverse società dal The Nasdaq Stock Market. Le società interessate includono Digital Brands Group, Lipella Pharmaceuticals, ZyVersa Therapeutics, Crown LNG Holdings, Brainstorm Cell Therapeutics, Wag! Group, Ontrak, TPI Composites, Embrace Change Acquisition Corp e ModivCare.
Tutti questi titoli erano stati sospesi dalle negoziazioni tra dicembre 2024 e agosto 2025 e non hanno più operato su Nasdaq dalla rispettiva data di sospensione. I delisting riguardano diversi tipi di strumenti, tra cui azioni ordinarie, warrant, unità e diritti.
La Nasdaq (NASDAQ:NDAQ) ha anunciado la retirada de listado de valores de varias empresas del The Nasdaq Stock Market. Las compañías afectadas incluyen Digital Brands Group, Lipella Pharmaceuticals, ZyVersa Therapeutics, Crown LNG Holdings, Brainstorm Cell Therapeutics, Wag! Group, Ontrak, TPI Composites, Embrace Change Acquisition Corp y ModivCare.
Todos estos valores habían sido suspendidos de negociación entre diciembre de 2024 y agosto de 2025 y no han operado en Nasdaq desde sus fechas de suspensión respectivas. Las exclusiones del listado afectan a diversos tipos de valores, incluyendo acciones comunes, warrants, unidades y derechos.
나스닥(NASDAQ:NDAQ)은 Nasdaq Stock Market에서 여러 회사의 증권 상장을 폐지한다고 발표했습니다. 영향을 받는 회사로는 Digital Brands Group, Lipella Pharmaceuticals, ZyVersa Therapeutics, Crown LNG Holdings, Brainstorm Cell Therapeutics, Wag! Group, Ontrak, TPI Composites, Embrace Change Acquisition Corp, 및 ModivCare가 포함됩니다.
이들 모든 증권은 2024년 12월부터 2025년 8월까지 거래가 중단되었으며 각 중단 날짜 이후로 Nasdaq에서 거래되지 않았습니다. 상장폐지는 보통주, 워런트, 유닛(Unit) 및 권리(Rights) 등 다양한 유형의 증권에 영향을 미칩니다.
Nasdaq (NASDAQ:NDAQ) a annoncé la radiation des valeurs de plusieurs entreprises du Nasdaq Stock Market. Les sociétés concernées comprennent Digital Brands Group, Lipella Pharmaceuticals, ZyVersa Therapeutics, Crown LNG Holdings, Brainstorm Cell Therapeutics, Wag! Group, Ontrak, TPI Composites, Embrace Change Acquisition Corp et ModivCare.
Toutes ces valeurs avaient été suspendues de négociation entre décembre 2024 et août 2025 et n'ont pas été négociées sur Nasdaq depuis leurs dates de suspension respectives. Les radiations concernent divers types de valeurs, y compris des actions ordinaires, des warrants, des unités et des droits.
Nasdaq (NASDAQ:NDAQ) hat die Delistung von Wertpapieren mehrerer Unternehmen vom Nasdaq Stock Market angekündigt. Zu den betroffenen Unternehmen gehören Digital Brands Group, Lipella Pharmaceuticals, ZyVersa Therapeutics, Crown LNG Holdings, Brainstorm Cell Therapeutics, Wag! Group, Ontrak, TPI Composites, Embrace Change Acquisition Corp und ModivCare.
Alle diese Wertpapiere wurden zwischen Dezember 2024 und August 2025 vorübergehend vom Handel ausgesetzt und seit ihren jeweiligen Aussetzungstagen nicht mehr an der Nasdaq gehandelt. Die Delistings betreffen verschiedene Arten von Wertpapieren, darunter Stammaktien, Warrants, gewöhnliche Anteile, Units und Rights.
نازداك (NASDAQ:NDAQ) أعلنت عن إزالة الإدراج لأسهم عدة شركات من سوق ناسداك. الشركات المتأثرة تشمل Digital Brands Group و Lipella Pharmaceuticals و ZyVersa Therapeutics و Crown LNG Holdings و Brainstorm Cell Therapeutics و Wag! Group و Ontrak و TPI Composites و Embrace Change Acquisition Corp و ModivCare.
لقد تم تعليق جميع هذه الأوراق المالية من التداول بين ديسمبر 2024 و أغسطس 2025 ولم تتداول على ناسداك منذ تواريخ التوقيف المعنية. يشمل الإغلاق من القائمة أنواعاً مختلفة من الأوراق المالية بما في ذلك الأسهم العادية، والـ warrants، والوحدات، وحقوق الملكية.
纳斯达克(NASDAQ:NDAQ)宣布自纳斯达克交易所下市多家公司的证券。受影响的公司包括 Digital Brands Group、Lipella Pharmaceuticals、ZyVersa Therapeutics、Crown LNG Holdings、Brainstorm Cell Therapeutics、Wag! Group、Ontrak、TPI Composites、Embrace Change Acquisition Corp 和 ModivCare。
所有这些证券在 2024年12月至2025年8月之间已被暂停交易,且自各自的暂停日期起未在纳斯达克交易所交易。退市涉及多种证券类型,包括普通股、认股权证、单位和权利等。
- None.
- Delisting of 10 companies' securities from Nasdaq indicates potential market stress or compliance issues
- Multiple companies across different sectors affected, suggesting broader market concerns
- Loss of trading venue for affected securities impacts their liquidity and accessibility
Insights
Nasdaq's delisting of multiple companies signals regulatory compliance issues and creates significant trading limitations for affected securities.
Nasdaq has announced the formal delisting of securities from 10 different companies whose trading had already been suspended for periods ranging from approximately 1-9 months. This multi-company delisting action affects various security types including common stocks, warrants, ordinary shares, units, and rights.
The affected companies represent diverse sectors including healthcare (Lipella Pharmaceuticals, ZyVersa Therapeutics, Brainstorm Cell Therapeutics, Ontrak), manufacturing (TPI Composites), energy (Crown LNG), consumer services (Wag! Group, ModivCare), retail (Digital Brands Group), and SPACs (Embrace Change Acquisition).
This formal delisting follows prolonged trading suspensions, indicating these companies likely failed to meet Nasdaq's continued listing requirements. Typical causes include: minimum bid price requirements (stock trading below
For shareholders, this delisting creates significant implications. The securities will likely move to over-the-counter (OTC) markets where trading volumes typically decrease dramatically, leading to reduced liquidity, wider bid-ask spreads, and potentially lower valuations. Institutional investors often have mandates preventing ownership of non-exchange-listed securities, forcing additional selling pressure.
Additionally, delisted companies face more limited access to capital markets, reduced analyst coverage, and diminished media attention, creating challenges for future financing and growth. The clustering of multiple delistings in this announcement reflects the challenging market environment where smaller capitalization companies have struggled to maintain exchange compliance.
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the warrants of Digital Brands Group, Inc. Digital Brands Group, Inc.’s warrants were suspended on December 18, 2024 and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Lipella Pharmaceuticals Inc. Lipella Pharmaceuticals Inc.’s stock was suspended on June 20, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.’s common stock was suspended on July 17, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the ordinary shares and warrants of Crown LNG Holdings Limited. Crown LNG Holdings Limited’s securities were suspended on July 17, 2025 and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Brainstorm Cell Therapeutics Inc. Brainstorm Cell Therapeutics Inc.’s stock was suspended on July 18, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock and warrants of Wag! Group Co. Wag! Group Co.’s securities were suspended on July 30, 2025 and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Ontrak, Inc. Ontrak, Inc.’s stock was suspended on August 18, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of TPI Composites, Inc. TPI Composites, Inc.’s stock was suspended on August 19, 2025 and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the ordinary shares, units, warrants, and rights of Embrace Change Acquisition Corp. Embrace Change Acquisition Corp’s securities were suspended on August 21, 2025 and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of ModivCare Inc. ModivCare Inc.’s stock was suspended on August 28, 2025 and has not traded on Nasdaq since that time.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.